These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [First Hungarian report of olopatadine eyedrop therapy in children and adults suffering from seasonal allergic conjunctivitis]. Endre L, Hidasi V. Orv Hetil; 2006 Sep 10; 147(36):1741-3. PubMed ID: 17087018 [Abstract] [Full Text] [Related]
11. Efficacy and comfort of olopatadine 0.2% versus epinastine 0.05% ophthalmic solution for treating itching and redness induced by conjunctival allergen challenge. Mah FS, Rosenwasser LJ, Townsend WD, Greiner JV, Bensch G. Curr Med Res Opin; 2007 Jun 10; 23(6):1445-52. PubMed ID: 17559743 [Abstract] [Full Text] [Related]
12. Comparison of preservative-free ketotifen fumarate and preserved olopatadine hydrochloride eye drops in the treatment of moderate to severe seasonal allergic conjunctivitis. Mortemousque B, Bourcier T, Khairallah M, Messaoud R, Brignole-Baudouin F, Renault D, Rebika H, Brémond-Gignac D, Ketotifen Study Group. J Fr Ophtalmol; 2014 Jan 10; 37(1):1-8. PubMed ID: 24388379 [Abstract] [Full Text] [Related]
15. Treatment of allergic conjunctivitis: results of a 1-month, single-masked randomized study. Figus M, Fogagnolo P, Lazzeri S, Capizzi F, Romagnoli M, Canovetti A, Iester M, Ferreras A, Rossetti L, Nardi M. Eur J Ophthalmol; 2010 Jan 10; 20(5):811-8. PubMed ID: 20383847 [Abstract] [Full Text] [Related]